Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Efficacy of antibiotic therapy for SAPHO syndrome is lost after its discontinuation: interventional study
Arthritis Research & Therapy, 09/23/09
Assmann G et al. – For the period of application, the antibiotic therapy seems to have controlled the disease. After antibiotics discontinuation however, disease relapse was observed. SAPHO syndrome thus groups with other chronic inflammatory arthropathies with a need of permanent therapy.
Methods- 37 patients met the clinical criteria of SAPHO syndrome
- 21 underwent a needle biopsy of the osteitis lesion; 14 of them showed positive bacteriological cultures for Propionibacterium acnes
- 30 patients (14 bacteriological positive and 16 without biopsy) treated with antibiotics for 16 weeks
- Activity of skin disease and osteitis assessed by physician using a scoring model (from 0 to 6)
- Patients completed a health assessment score (HAS, from 0 to 6).
- ESR was determined and a MRI (of the osteitis lesion, radiologic activity score from 0 to 2) was performed in week 1 (W1), week 16 (W16), and week 28 (W28, 12 weeks after antibiotics
- Twenty-seven patients continued the medication (azithromycin, n=25, 500 mg twice a week, clindamycin, n=1, 300 mg daily, or doxycycline, n=2, 100 mg daily) for 16 weeks
- After W16 the scores for MRI , skin activity , osteitis activity , and HAS decreased significantly
- Followed by increasing values for MRI scores , skin activity , osteitis activity , and HAS from W16 to W28
- Comparison of the scores in W1 and W28 showed no significant differences
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Can tumor necrosis factor inhibitors be safely used in pregnancy?
Journal of Rheumatology, 12/17/09
The effect of anti-TNF agent on oxidation status in patients with ankylosing spondylitis
Clinical Rheumatology, 12/17/09
Unresponsiveness to colchicine therapy in patients with familial Mediterranean fever homozygous for the M694V mutation
Journal of Rheumatology, 12/17/09
Today in Other Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
A case of granulomatous mastitis with erythema nodosum and arthritis
Rheumatology International, 12/19/09
Better assessment of physical function: item improvement is neglected but essential
Arthritis Research & Therapy, 12/19/09
A case of juvenile idiopathic polyarticular arthritis complicated by IgA deficiency in 22q11 deletion syndrome
Rheumatology International, 12/19/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


